Search results
King honors three with Sullivan Award
Bristol Herald Courier· 1 day agoKing University presented the 2024 Algernon Sydney Sullivan Award to three recipients during Saturday’s commencement ceremony. This year’s awards were...
As summer nears, state tourism businesses pin hopes on winning more Pure Michigan funding
Detroit News· 1 day agoAs Michigan gears up for another summer tourism season, businesses are hoping to cash in on what...
The end of coral reefs as we know them
Vox· 5 days agoMore than five years ago, the world’s top climate scientists made a frightening prediction: If the planet warms by 1.5 degrees Celsius, relative to...
Author to speak on 'extreme survival'
The Eagle-Tribune· 3 days agoLooking for something new to do outside of southern New Hampshire? Check out the following upcoming events.
Hemogenyx Pharmaceuticals PLC Announces Final Results
Morningstar· 6 days agoLONDON, UK / ACCESSWIRE / April 25, 2024 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases ...
Frontier myth vilified the California grizzly. Science tells a new story.
Washington Post via Yahoo News· 4 days agoCorrection: A previous version of this article mistakenly described Alexis Mychajliw as an ecologist...
In a communist stronghold, capitalists become an economic lifeline - The Boston Globe
The Boston Globe· 1 day agoCuba is confronting its worst financial crisis in decades, so the island’s communist leaders are...
One of Amazon's Most Popular Camping Lanterns That's 'Very, Very Bright' Is Now Just $22 for Two
Men's Journal· 5 days agoThe Consciot LED Camping Lanterns, 2-Pack. Men’s Journal aims to feature only the best products and...
What Is a ‘Decent Wage’? France’s Michelin Raises a Debate.
New York Times· 5 days agoThousands of workers in Asia, Europe and the United States at the lower end of the company’s pay...
Hemogenyx Pharmaceuticals PLC Announces Final Results
Digital Journal· 6 days agoLONDON, UK / ACCESSWIRE / April 25, 2024 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases ...
